DeutschNewstral
Article
bizjournals.com on 2018-03-20 22:34
Peninsula biotech lands $150 million deal to tackle brain diseases
Related news
- How this Peninsula biotech is hurdling the blood-brain barrier to tackle diseasesbizjournals.com
- Potential Peninsula biotech IPO lands $46 millionbizjournals.com
- Aiming at genetic diseases, Peninsula stealth biotech emerges with $191Mbizjournals.com
- Peninsula biotech snags $45M to tackle rare anemiabizjournals.com
- Global vision for women's health lands Peninsula biotech $31Mbizjournals.com
- Aiming at genetic diseases, Peninsula stealth biotech emerges with $191 millionbizjournals.com
- Peninsula biotech, Big Pharma ink $700M upfront deal around neurodegenerative diseasesbizjournals.com
- Bain, Pfizer launch biotech startup to tackle brain disordersbizjournals.com
- With $30M and Stanford immunotherapy pioneer, biotech eyes one of the toughest brain diseasesbizjournals.com
Robin Williams' Widow Shares His Struggles, Talks Brain Diseases With Biotech CEOsForbes- Big biotech, UCs launch $53M effort targeting Alzheimer's, other brain diseasesbizjournals.com
- MGilead strikes deal with biotech Goldfinch Bio to tackle kidney diseasesmarketwatch.com
- How AI, big Lilly deal could help this Peninsula biotech tackle ALSbizjournals.com
- Peninsula biotech looks to raise $144M after childhood brain cancer data, big stock jumpbizjournals.com
- Looking to plant more biotech seedlings, Peninsula genetic disease firm lands $300Mbizjournals.com
- Peninsula biotech toolmaker lands $165M to rewrite how DNA gets madebizjournals.com
- After half-billion dollars, nearly quarter century, Peninsula biotech lands its first FDA drug approvalbizjournals.com
Guest Commentary: Children, tackle football and possible dangers of brain diseasesDenver Post
Study: CTE, other brain diseases can start earlier if tackle football played before age 12USA today